Share
851 Posts.
lightbulb Created with Sketch. 34
clock Created with Sketch.
26/02/19
13:11
Share
Originally posted by Beale
↑
What are the chances that inside the half year results next week this circus that is suda can receive a nice polish up and us shareholders can get some sort of concise summary of where things are up and I mean
1. Zolpimist first milestone payments,
2. Zolpimist first royalty timelines
3. Zolpi marketing application lodgement updates,
4. Artimist key timeline update TGA and sale,
5. What's happened to Zolpi Euro and 002 deals
6. Pfizer update when does the option expire and what next ...?
7. Anagrelide timelines
8. Our priority project midazolam.... Not a word on it since it became a "priority"
9. Any kind of update on 001 and strides and give some timelines,
10.Address the development costs associated with the Strides deal
11. Update on Co development deals in the pipeline and special attention to Cannabanoid.
12. 001 Euro deal update
13.CY guidance
There is so much to update the market on yet we continuously receive nothing from the guys. Not a thing. We need timelines, future deals, liquidity conversations inside all communication. Explain to the investor how we wont run out of cash please Mr Carter and how this can prosper and inside what sort of timeline. Do it to the best of your knowledge. You consistently ignore the fundamentals mate.
Expand
exactly ... so many products on the line , one already in market shelf. the sp should be $20 and not below biotech companies still in stage 1 trials !!!